Cover Image
市場調查報告書

Sinil Pharmaceutical Co., Ltd的產品平台分析

Sinil Pharmaceutical Co., Ltd - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 318944
出版日期 內容資訊 英文 17 Pages
訂單完成後即時交付
價格
Back to Top
Sinil Pharmaceutical Co., Ltd的產品平台分析 Sinil Pharmaceutical Co., Ltd - Product Pipeline Review - 2014
出版日期: 2014年11月14日 內容資訊: 英文 17 Pages
簡介

Sinil Pharmaceutical Co., Ltd(Sinil Pharm)是總公司設立於韓國的製藥企業,正在製造、銷售各種疾病治療用製藥產品,注射及口服藥。

本報告提供Sinil Pharmaceutical Co., Ltd的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Sinil Pharmaceutical Co., Ltd的基本資料

  • Sinil Pharmaceutical Co., Ltd概要
  • 主要資訊
  • 企業資料

Sinil Pharmaceutical Co., Ltd:R&D概要

  • 主要的治療範圍

Sinil Pharmaceutical Co., Ltd:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Sinil Pharmaceutical Co., Ltd:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Sinil Pharmaceutical Co., Ltd:藥物簡介

  • SI-000513
  • SI-001002
  • Drug for Undisclosed Indication
  • SI-000701

Sinil Pharmaceutical Co., Ltd:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06493CDB

Summary

Global Markets Direct's, 'Sinil Pharmaceutical Co., Ltd - Product Pipeline Review - 2014', provides an overview of the Sinil Pharmaceutical Co., Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sinil Pharmaceutical Co., Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Sinil Pharmaceutical Co., Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Sinil Pharmaceutical Co., Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Sinil Pharmaceutical Co., Ltd's pipeline products

Reasons to buy

  • Evaluate Sinil Pharmaceutical Co., Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Sinil Pharmaceutical Co., Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Sinil Pharmaceutical Co., Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Sinil Pharmaceutical Co., Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sinil Pharmaceutical Co., Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Sinil Pharmaceutical Co., Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Sinil Pharmaceutical Co., Ltd Snapshot
    • Sinil Pharmaceutical Co., Ltd Overview
    • Key Information
    • Key Facts
  • Sinil Pharmaceutical Co., Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Sinil Pharmaceutical Co., Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Sinil Pharmaceutical Co., Ltd - Pipeline Products Glance
    • Sinil Pharmaceutical Co., Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Sinil Pharmaceutical Co., Ltd - Drug Profiles
    • SI-000513
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SI-001002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SI-000701
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Sinil Pharmaceutical Co., Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sinil Pharmaceutical Co., Ltd, Key Information
  • Sinil Pharmaceutical Co., Ltd, Key Facts
  • Sinil Pharmaceutical Co., Ltd - Pipeline by Indication, 2014
  • Sinil Pharmaceutical Co., Ltd - Pipeline by Stage of Development, 2014
  • Sinil Pharmaceutical Co., Ltd - Monotherapy Products in Pipeline, 2014
  • Sinil Pharmaceutical Co., Ltd - Preclinical, 2014
  • Sinil Pharmaceutical Co., Ltd - Discovery, 2014

List of Figures

  • Sinil Pharmaceutical Co., Ltd - Pipeline by Stage of Development, 2014
  • Sinil Pharmaceutical Co., Ltd - Monotherapy Products in Pipeline, 2014
Back to Top